Table 6.
Determination of cytotoxic effect using MTT assay towards HEK293 and HEPG2 cell lines.
| Compound | HEK293 | HEPG2 | HT29 |
|---|---|---|---|
| 9 | 3.64 ± 0.23 | 1.94 ± 0.67 | – |
| 13 | 5.73 ± 1.64 | 1.92 ± 0.85 | 1.85 ± 0.21* |
| 14 | 5.99 ± 1.05 | 4.2 ± 0.71 | 1.83 ± 0.46* |
| 15 | 8.33 ± 0.75 | 2.53 ± 0.82 | 10.7 ± 3.25* |
| 42 | 5.38 ± 0.35 | 4.88 ± 0.31 | – |
| 44 | 3.57 ± 0.25 | 4.94 ± 0.56 | – |
| 45 | 48.47 ± 1.50 | 26.64 ± 2.36 | – |
| Etoposide | 1.91 ± 0.97 | 5.01 ± 0.22 | – |
| Doxorubicin | 6.52 ± 0.13** | – | – |
In vitro growth inhibitory activity of compounds presented as an EC50 ± SD (µM) value—a concentration that inhibits 50% of mammalian cell growth.
*Antiproliferative activity of compounds 13–15 published previously26.
**Antiproliferative activity of doxorubicin published previously32. In this assay, the EC50 value of etoposide was recorded as a positive control.